Study to Evaluatethe Bioavailability and Food Effect Lenalidomide as an Oral Suspension

Clinical trial NCT02521714 · COMPLETED

Trial details

NCT number: NCT02521714
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2015-08-14
Primary completion: 2015-09-23
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.